Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
J Am Acad Dermatol ; 64(6): 1159-63, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20638154

ABSTRACT

Palmar fasciitis and polyarthritis syndrome is a rare, disabling, paraneoplastic condition of unknown pathogenesis. There is no known effective treatment, although the condition may be halted by control of the cancer. Previously reported cases have mostly been in patients with advanced ovarian malignancies. We present the case of a 69-year-old woman with this condition in association with bladder carcinoma, together with a review of the literature and discussion of possible therapeutic options.


Subject(s)
Arthritis/complications , Carcinoma, Transitional Cell/complications , Fasciitis/complications , Paraneoplastic Syndromes/complications , Urinary Bladder Neoplasms/complications , Aged , Arthritis/diagnosis , Contracture/etiology , Diagnosis, Differential , Female , Hand , Humans , Paraneoplastic Syndromes/diagnosis , Syndrome
3.
Pediatr Dermatol ; 24(5): 499-500, 2007.
Article in English | MEDLINE | ID: mdl-17958795

ABSTRACT

We present a 14-year-old girl with self-induced areas of hypo- and hyperpigmenation on her forearm as a result of applying 10 blasts of an asthmatic aerosol inhaler directly to her skin. We emphasize the importance of being aware of potential danger associated with the common metered-dose inhaler when it is misused.


Subject(s)
Albuterol/adverse effects , Asthma/drug therapy , Bronchodilator Agents/adverse effects , Self-Injurious Behavior , Skin Diseases/chemically induced , Skin Pigmentation/drug effects , Adolescent , Albuterol/administration & dosage , Bronchodilator Agents/administration & dosage , Female , Humans , Hyperpigmentation/chemically induced , Hypopigmentation/chemically induced , Metered Dose Inhalers
4.
Ecology ; 88(5): 1225-31, 2007 May.
Article in English | MEDLINE | ID: mdl-17536408

ABSTRACT

Many natural enemies do not immediately kill their host, and the lag this creates between attack and host death results in mixed populations of uninfected and infected hosts. Both competition and parasitism are known to be major structuring forces in ecological communities; however, surprisingly little is known about how the competitive nature of infected hosts could affect the survival and dynamics of remaining uninfected host populations. Using a laboratory system comprising the Indian meal moth, Plodia interpunctella, and a solitary koinobiont parasitoid, Venturia canescens, we address this question by conducting replicated competition experiments between the unparasitized and parasitized classes of host larvae. For varying proportions of parasitized host larvae and competitor densities, we consider the effects of competition within (intraclass) and between (interclass) unparasitized and parasitized larvae on the survival, development time, and size of adult moths and parasitoid wasps. The greatest effects were on survival: increased competitor densities reduced survival of both parasitized and unparasitized larvae. However, unparasitized larvae survival, but not parasitized larvae survival, was reduced by increasing interclass competition. To our knowledge, this is the first experimental demonstration of the competitive superiority of parasitized over unparasitized hosts for limiting resources. We discuss possible mechanisms for this phenomenon, why it may have evolved, and its possible influence on the stability of host-parasite dynamics.


Subject(s)
Ascomycota/growth & development , Host-Parasite Interactions , Moths/parasitology , Animals , Ecosystem , Larva , Population Dynamics , Species Specificity , Survival Rate
5.
Pediatr Allergy Immunol ; 15(3): 221-9, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15209954

ABSTRACT

We investigated the natural history of atopic dermatitis (AD) in a population-based birth cohort and assessed whether children at risk of visible eczema at 5 years of age can be identified from total immunoglobulin E (IgE) levels measured at 8, 12 and 18 months. AD data collected included a whole body examination for visible eczema at 49 months (4 years) and 61 months (5 years) of age and parent completed questionnaire data throughout their early lives. Children were divided into four groups based on their natural history of early AD: persistent (AD at 1, 6, 18, 30 and 42 months, n = 34), intermittent early onset (before 18 months of age, n = 495), intermittent late onset (18-42 months of age, n = 273) and unaffected (n = 429). Visible eczema at 5 years of age was present in 12.2% (117/957) (95% confidence interval [CI] 10.1-14.3%) of the children. Levels of total IgE at 8, 12 and 18 months of age were associated with early onset of AD, but not with AD of later onset. For all four natural history groups, the geometric mean total IgE at 12 months was higher in those who subsequently had visible eczema than those who did not. However, the degree of overlap was such that total IgE at 12 months of age was a poor predictor of eczema at age five. A cutoff point of 78 kU/l had the highest positive predictive value for visible eczema at 5 years of age of 28.6%, with a sensitivity of 12% and specificity of 95%.


Subject(s)
Dermatitis, Atopic/immunology , Immunoglobulin E/blood , Age Factors , Child, Preschool , Cohort Studies , Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/etiology , Eczema/immunology , Female , Humans , Infant , Infant, Newborn , Male , Predictive Value of Tests , Prevalence , ROC Curve , Regression Analysis , Skin Tests , Surveys and Questionnaires
6.
Hum Mol Genet ; 11(17): 2005-14, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12165562

ABSTRACT

Distinct germline mutations in the gene (GJB3) encoding connexin 31 (Cx31) underlie the skin disease erythrokeratoderma variabilis (EKV) or sensorineural hearing loss with/without peripheral neuropathy. Here we describe a number of functional analyses to investigate the effect of these different disease-associated Cx31 mutants on connexon trafficking and intercellular communication. Immunostaining of a biopsy taken from an EKV patient harbouring the R42P mutation revealed sparse epidermal staining of Cx31, and, when present, it had a perinuclear localization. Transfection and microinjection studies in both keratinocytes and fibroblast cell lines also demonstrated that R42P and four other EKV-associated mutant Cx31 proteins displayed defective trafficking to the plasma membrane. The deafness/neuropathy only mutant 66delD had primarily a cytoplasmic localization, but some protein was visualized at the plasma membrane in a few transfected cells. Both 66delD- and R32W-Cx31/EGFP proteins had significantly impaired dye transfer rates compared to wild-type Cx31/EGFP protein. A striking characteristic feature observed with the dominant skin disease Cx31 mutations was a high incidence of cell death. This was not observed with wild-type, R32W 66delD Cx31 proteins. In conclusion, we have identified some key cellular phenotypic differences with respect to disease-associated Cx31 mutations.


Subject(s)
Connexins/genetics , Keratosis/genetics , Peripheral Nervous System Diseases/genetics , Biopsy , Cell Communication/physiology , Cell Death/physiology , Cell Membrane , Connexins/metabolism , DNA Primers/chemistry , Fibroblasts/metabolism , Fibroblasts/pathology , Green Fluorescent Proteins , Humans , Keratinocytes/metabolism , Keratinocytes/pathology , Keratosis/metabolism , Keratosis/pathology , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Mutagenesis, Site-Directed , Peripheral Nervous System Diseases/metabolism , Recombinant Fusion Proteins/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...